CTMC

CTMC is a purpose-driven cell therapy accelerator that partners with innovative biotech companies to bring transformative cancer treatments to patients faster. By integrating deep manufacturing expertise with financial and strategic co-development support, CTMC helps programs efficiently progress from early-stage development through clinical proof of concept. With a model centered around partnerships, platforms, and people, CTMC has enabled the successful filing of eight INDs in just three years. The company’s mission is to expand global access to cell therapies by building scalable manufacturing capabilities and empowering institutions—such as hospitals and cancer centers—to deliver these lifesaving treatments closer to patients.